- FDA has determined that the inspection classification of ST PHARM's facility is "no action indicated" ("NAI"). 

- FDA has concluded that this inspection is ''closed''

- ST PHARM's banwol campus 'oligo plants' is Asia's first USA FDA cGMP certified oligo manufacturing facility